Toward inflammation-free therapeutics in Alzheimer's disease

Cited 2 time in webofscience Cited 0 time in scopus
  • Hit : 203
  • Download : 0
DC FieldValueLanguage
dc.contributor.authorKim, Chan Hyukko
dc.contributor.authorChung, Won-Sukko
dc.date.accessioned2022-11-10T03:02:10Z-
dc.date.available2022-11-10T03:02:10Z-
dc.date.created2022-11-07-
dc.date.created2022-11-07-
dc.date.created2022-11-07-
dc.date.issued2022-09-
dc.identifier.citationNATURE MEDICINE, v.28, no.9, pp.1765 - 1766-
dc.identifier.issn1078-8956-
dc.identifier.urihttp://hdl.handle.net/10203/299465-
dc.description.abstractAn engineered fusion protein exploits the efferocytosis pathway to clear amyloid-beta (A beta) from the brain without eliciting the severe inflammatory adverse effects associated with A beta-targeting antibody-based immunotherapies. In mouse models of Alzheimer's disease, this approach induced robust clearance of A beta without inflammation, improved synapse protection, and decreased brain microhemorrhage, which result in superior behavioral recovery.-
dc.languageEnglish-
dc.publisherNATURE PORTFOLIO-
dc.titleToward inflammation-free therapeutics in Alzheimer's disease-
dc.typeArticle-
dc.identifier.wosid000851351400002-
dc.identifier.scopusid2-s2.0-85138490147-
dc.type.rimsART-
dc.citation.volume28-
dc.citation.issue9-
dc.citation.beginningpage1765-
dc.citation.endingpage1766-
dc.citation.publicationnameNATURE MEDICINE-
dc.identifier.doi10.1038/s41591-022-01972-3-
dc.contributor.localauthorKim, Chan Hyuk-
dc.contributor.localauthorChung, Won-Suk-
dc.description.isOpenAccessN-
dc.type.journalArticleEditorial Material-
Appears in Collection
BS-Journal Papers(저널논문)
Files in This Item
There are no files associated with this item.
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 2 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0